---
title: "Humanwell Healthcare Registers Antidepression Drug"
date: "2025-02-11 10:43:22"
summary: "Humanwell Healthcare  obtained drug registration from China's drug administrator for desvenlafaxine succinate sustained-release tablets. The drug is indicated for the treatment of adult depression, according to a Tuesday filing with the Shanghai bourse."
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Humanwell Healthcare obtained drug registration from China's drug administrator for desvenlafaxine succinate sustained-release tablets.

The drug is indicated for the treatment of adult depression, according to a Tuesday filing with the Shanghai bourse.

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250210:G2465956:0/)
